ABSTRACT purpose. To compare the short-term outcome of the Multigen Plus system using a symmetric ceramic femoral component with that of 2 metallic total knee replacement (TKR) systems. Methods. 60 patients (62 knees) with osteoarthritis or rheumatoid arthritis underwent primary TKR using the Genia system (n=20), the Multigen Plus system (n=17), and the Multigen Plus system with a ceramic femoral component (n=25). Outcome was evaluated pre-and post-operatively (at 3, 12, and 24 months) using the Hospital for Special Surgery (HSS) score, the Western Ontario and McMaster Universities (WOMAC) score, and the Short-Form 36 (SF-36) score. results. The 3 groups did not differ significantly at all 4 time points in terms of the HSS score, WOMAC score, and SF-36 score. The range of motion was significantly less in patients treated with the Genia system. Postoperatively, the HSS and WOMAC scores improved significantly in all 3 groups, whereas the SF-36 score improved significantly (at 12 and 24 months) only in patients treated with the Multigen Total knee replacement system with a ceramic femoral component versus two traditional metallic designs: a prospective short-term study Plus system with a ceramic femoral component. The implant position in most patients was optimal. All radiolucent lines were within 1 mm and did not progress. conclusion. The short-term outcome of the 3 TKR systems was comparable. Ceramic femoral components performed comparably to traditional metallic designs.
but the choices are limited. 6 Femoral components are mainly made of cobalt-chromium alloys, liners of ultrahigh-molecular-weight polyethylene (UHMWPE), and tibial components of cobalt-chromium or titanium alloys. Ceramics have good biocompatibility and wear properties in relation to UHMWPE. 5 They have high chemical and mechanical stability, and extreme resistance to wear and corrosion, owing to the lack of an electrochemical reaction and excellent tribology. 8 In the late 1970s, alumina ceramics and UHMWPE started to be used in TKR, 9 but their brittleness is high. TKR components are under high stress, especially the femoral component near the corners of femoral resections and at points of contact with the polyethylene. 6 Composite matrix materials containing mainly alumina and zirconia increase the bending strength and fracture toughness. 1, 6 This study compared the short-term outcome of the Multigen Plus TKR system (using a symmetric ceramic femoral component) with that of 2 metallic TKR systems.
Materials and Methods
This study was approved by the ethics committee of our hospital, and informed consent was given by each patient. Between 2006 and 2009, 60 patients (62 knees) with osteoarthritis or rheumatoid arthritis underwent primary TKR using the Genia system (n=20), the Multigen Plus system (n=17), and the Multigen Plus system with a ceramic femoral component (n=25).
The Genia system (Orhodynamics GmbH, Luebeck, Germany) is a cemented posteriorstabilised, posterior-cruciate-ligament-scarifying implant with a rotating, ultracongruent insert made of standard polyethylene. Both the femoral and tibial components are made of cobalt-chromium alloy. The Multigen Plus system (Lima Corporate, Villanova di San Daniele, Udine, Italy) uses an unconstrained bicondylar design. It consists of an asymmetric, cruciate-retaining, cemented metallic femoral (made of Co28Cr6Mo) and tibial (made of Ti6Al4V) components, and a fixed-bearing UHMWPE liner. The Multigen Plus system with a ceramic femoral component (Lima Corporate, Villanova di San Daniele, Udine, Italy) consists of a BIOLOX Delta ceramic femoral component. Its design is identical to that of the Multigen Plus Knee, except for having a symmetric anterior surface.
All TKRs were implanted in a standardised manner by 2 experienced orthopaedic surgeons, using the Payr's approach. Intravenous cefuroxime (1.5 g) was given as peri-operative prophylaxis. A torniquet (300 mm Hg) was used. The lateral patellar facet was smoothened and denervation performed. Perfect positioning of the implant components was achieved. Both the femoral and tibial components were fixed using polymethylmethacrylate cement (Refobacin Plus Bone Cement, Biomet Deutschland, Berlin, Germany).
Postoperatively, analgesia was given. Thromboembolism prophylaxis (daily subcutaneous low-molecular-weight heparin and compression stockings) was given during hospitalisation and follow-up. Full weight-bearing mobilisation using 2 forearm crutches and a 4-point gait was started on day 2.
Outcome was evaluated pre-and post-operatively (at 3, 12, and 24 months) using the Hospital for Special Surgery (HSS) score, the Western Ontario and McMaster Universities (WOMAC) score, and the Short-Form 36 (SF-36) score. 2, [10] [11] [12] The maximum HSS score is 100; the HSS includes domains of pain 
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(30), function (22) , motion (18) , muscle strength (10), deformity (10) , and instability (10); 62% were subjective and 38% were objective criteria. Radiolucent lines and osteolysis of the femoral and tibial bone stock were evaluated using standardised anteroposterior and lateral radiographs (Fig. 1) Table 1 ]. The range of motion was significantly less in patients with the Genia system than those with the Multigen Plus system with a ceramic femoral component at 12 months (p=0.012, Mann-Whitney U test), and those with the Multigen Plus system at 24 months (p=0.012, Mann-Whitney U test), although the preoperative range of motion was highest in patients with the Genia system ( Table 1) .
After TKR, the HSS scores improved significantly in all 3 groups (p≤0.005, Wilcoxon signed rank test). Improvement was significant in patients with the Multigen Plus system between 3 and 12 months (p=0.001, Wilcoxon signed rank test) and in patients with the Multigen Plus system with a ceramic femoral component between 3 and 24 months (p=0.005, Wilcoxon signed rank test). In the pain domain, improvement was significant in all groups at all time points (p≤0.001, Wilcoxon signed rank test). In the function domain, improvement was significant in patients treated with the Genia system and the Multigen Plus system with a ceramic femoral component at all time points (p≤0.006, Wilcoxon signed rank test) and in patients treated After TKR, the WOMAC score improved significantly in all 3 groups (p≤0.003, Wilcoxon signed rank test). Improvement was significant in patients treated with Multigen Plus system with a ceramic femoral component between 3 and 24 months (p=0.002, Wilcoxon signed rank test). Improvement was not significant in all other groups between each postoperative time point (p≥0.056, Wilcoxon signed rank test).
After TKR, the SF-36 score improved in all 3 groups at all time points but not significantly after Bonferroni correction (p≥0.013, Wilcoxon signed rank test), except at 12 and 24 months in patients treated with the Multigen Plus system with a ceramic femoral component (p≤0.007, Wilcoxon signed rank test).
After TKR, the range of motion decreased in the early postoperative period (except for the Multigen Plus system group) and then improved maximally between 3 and 12 months, whereas the greatest pain relief was attained by 3 months. Improvement in the range of motion was significant at 24 months in patients treated with either of the Multigen Plus systems (p≤0.004, Wilcoxon signed rank test), whereas it was not significant in patients treated with the Genia system (p=0.384, Friedman test).
According to intramedullary insertion of a guiding device on the femoral side (6º) and an implant-specific slope of 7º for the 2 Multigen Plus systems and 5º for the Genia system, the optimum medial distal femur angle was 96º and the optimum posterior proximal tibia angle was 83º and 85°, respectively. The implant position in most patients was optimal or with slight deviations (Table 2 ). All radiolucent lines were within 1 mm and already noted at 3 months; there was no progression of radiolucent lines or osteolysis (Fig. 2) .
Five patients developed complications. One patient treated with the Genia system had infection after 13 months and the implant was revised. Another treated with the Genia system had instability in the flexion gap and was treated with the change of insert and soft-tissue balancing after 21 months. One patient treated with the Multigen Plus system had prolonged effusion, but no evidence of infection. Aspiration of the effusion did not resolve the symptoms, which was treated with subtotal excision of the synovial membrane at 8 months. One patient treated with the Multigen Plus system with a ceramic femoral component had infection secondary to direct trauma one week after surgery. The polyethylene insert was changed; antiseptic lavage and antibiotic treatment did not control the infection. A 2-staged procedure was performed to change for a semi-constrained metallic revision system. Another patient treated with the Multigen Plus system with a ceramic femoral component had posterolateral instability, owing to a ruptured posterior cruciate ligament after a trauma at 20 months. Revision to a larger insert improved stability.
discussion
Range of motion decreases immediately after TKR (owing to postoperative swelling and reduced proprioception and muscle strength), but improves significantly between 3 and 12 months and until 2 years. 13 The range of motion of all 3 groups was comparable with that of a high flexion TKR design (129.8º±5.2º) and a standard design (124.3º±9.2º). 14 The HSS scores of all 3 groups were comparable. The score was 85 to 93 after TKR with metallic implants at one year, 14, 15 whereas it was 86 after TKR with ceramic implants at 2 to 10 years. 5, 16, 17 Asymmetrical femoral designs attempt to simulate the normal knees. However, for the BIOLOX Delta ceramic femoral component, an asymmetrical design confers a higher risk of material fracture. Therefore, the ceramic femoral component has a symmetric ventral shield. Asymmetric designs are characterised by a raised lateral phalange (which is more anterior than the medial condyle) and an anatomically angled trochlea. Both the lateral phalange and the angled groove enable less subluxation and tilt of the patella. 3, 18 Surgical techniques (soft-tissue balancing and rotational alignment of the femoral and tibial components) affect patellar tracking. 3 In a study comparing patellar tracking of a symmetrical and an asymmetric TKR design using 45º merchant radiographs, patellar tracking was central in 54.9% and 54.5%, respectively. 19 However, measurements were based on radiographs at 45º knee flexion. Furthermore, the evaluated femoral components differed with respect to multiple design factors (total condylar vs. natural knee). 3, 19 Patellar tracking was clinically centralised in all our patients and patellar complications (subluxation, retropatellar pain) did not occur. These findings are consistent with those of a review. 3 Radiolucent lines around the components could result in implant loosening. Asymptomatic radiolucent lines (of up to 1 mm) around the tibial component are present in 3 to 9.5% of cases and around the femoral component in 3.6% cases. 5, 20 These lines occur in the early postoperative phase (up to 3 months) and can be interpreted as a stress-shielding phenomenon. 20 Material breakage is a serious problem of ceramics in joint replacement. 6 The ceramic knee prosthesis is fragile upon impact loading in vitro and in vivo. 5, 17, 21 Advances in ceramic technology have reduced the brittleness problem. In a finite element analysis, stresses close to the fatigue limit of 1150 MPa (provided by BIOLOX Delta Ceramic) occur at the intersections of resection surfaces and at the sharp change of sections at the distal part of the component during intra-operative impaction. 22 Therefore, precise intra-operative preparation of the bone stock and careful handling of the ceramic component is necessary. Limitations of this study were that the selected patients were not consecutive or randomised and the degree of the deformity was moderate in general. Hence, a selection bias existed. Furthermore, the size of the study group was small. Nonetheless, the 3 groups did not show significant differences in terms of preoperative demographics, functional scores, and comorbidities. Surgery was performed by only 2 surgeons using a standardised procedure. To evaluate adverse events (such as the fracture rate), larger and long-term studies are needed.
Short-term results of the Multigen Plus system using a ceramic femoral component were comparable to those of TKR systems using conventional metallic designs and bearing materials. Outcome following the use of asymmetric versus symmetric femoral components was also comparable. Ceramic implants are a solution for patients with allergies to metallic implant materials. 1, 6, 23 disclosure No conflicts of interest were declared by the authors.
